155 related articles for article (PubMed ID: 11472416)
1. Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):509-15. PubMed ID: 11472416
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1998 Dec; 114(3):333-8. PubMed ID: 9844040
[TBL] [Abstract][Full Text] [Related]
3. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
J Invest Dermatol; 1999 Aug; 113(2):267-71. PubMed ID: 10469315
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Br J Dermatol; 1998 Nov; 139(5):798-805. PubMed ID: 9892944
[TBL] [Abstract][Full Text] [Related]
5. Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients.
Rahoma SF; Sandhu HK; McDonagh AJ; Gawkrodger DJ; Weetman AP; Kemp EH
Br J Dermatol; 2012 Jul; 167(1):17-28. PubMed ID: 22329856
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor.
Gottumukkala RV; Waterman EA; Herd LM; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
J Invest Dermatol; 2003 Oct; 121(4):765-70. PubMed ID: 14632194
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.
Mandelcorn-Monson RL; Shear NH; Yau E; Sambhara S; Barber BH; Spaner D; DeBenedette MA
J Invest Dermatol; 2003 Sep; 121(3):550-6. PubMed ID: 12925214
[TBL] [Abstract][Full Text] [Related]
8. Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo.
Austin LM; Boissy RE
Am J Pathol; 1995 Jun; 146(6):1529-41. PubMed ID: 7778691
[TBL] [Abstract][Full Text] [Related]
9. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo.
Zhu MC; Liu CG; Wang DX; Zhan Z
Genet Mol Res; 2015 Dec; 14(4):16060-73. PubMed ID: 26662399
[TBL] [Abstract][Full Text] [Related]
10. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1997 Sep; 109(3):495-500. PubMed ID: 9328128
[TBL] [Abstract][Full Text] [Related]
11. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo.
Kroon MW; Kemp EH; Wind BS; Krebbers G; Bos JD; Gawkrodger DJ; Wolkerstorfer A; van der Veen JP; Luiten RM
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1172-5. PubMed ID: 22404127
[TBL] [Abstract][Full Text] [Related]
12. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay.
Kemp EH; Gawkrodger DJ; MacNeil S; Watson PF; Weetman AP
J Invest Dermatol; 1997 Jul; 109(1):69-73. PubMed ID: 9204957
[TBL] [Abstract][Full Text] [Related]
13. gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
Kierstead LS; Ranieri E; Olson W; Brusic V; Sidney J; Sette A; Kasamon YL; Slingluff CL; Kirkwood JM; Storkus WJ
Br J Cancer; 2001 Nov; 85(11):1738-45. PubMed ID: 11742496
[TBL] [Abstract][Full Text] [Related]
14. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
[TBL] [Abstract][Full Text] [Related]
15. Characterization of vitiligo antigens.
Cui J; Arita Y; Bystryn JC
Pigment Cell Res; 1995 Feb; 8(1):53-9. PubMed ID: 7792255
[TBL] [Abstract][Full Text] [Related]
16. A novel splice variant of Pmel17 expressed by human melanocytes and melanoma cells lacking some of the internal repeats.
Nichols SE; Harper DC; Berson JF; Marks MS
J Invest Dermatol; 2003 Oct; 121(4):821-30. PubMed ID: 14632201
[TBL] [Abstract][Full Text] [Related]
17. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
Eggleton P; Ward FJ; Johnson S; Khamashta MA; Hughes GR; Hajela VA; Michalak M; Corbett EF; Staines NA; Reid KB
Clin Exp Immunol; 2000 May; 120(2):384-91. PubMed ID: 10792392
[TBL] [Abstract][Full Text] [Related]
18. Hashimoto's thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases.
Gong Q; Li X; Gong Q; Zhu W; Song G; Lu Y
Arch Dermatol Res; 2016 May; 308(4):277-81. PubMed ID: 27020052
[TBL] [Abstract][Full Text] [Related]
19. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of melanocytes in vitiligo results from antibody penetration.
Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
